Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
HYDROSPACE
SpaceIT Hydrogel System for Perirectal Spacing
- NCT06451614 ↗
- Active, not recruiting
- Boston Scientific Corporation
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- SpaceIT Hydrogel System for Perirectal Spacing in Subjects With Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT)
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- SpaceIT Hydrogel System; Commercially available Boston Scientific Spacer
- Arms
- SpaceIT Hydrogel System · Experimental
- Commercially available Boston Scientific Spacer · Active comparator
- Enrollment
- 230 (estimated)
- Primary outcomes
- Primary Safety Endpoint - Acute Grade 3 or greater adverse events.
- Primary Effectiveness Endpoint - 25% reduction in the volume of the rectum receiving 90% of the prescribed radiation dose
- Sponsor
- Boston Scientific Corporation
- Start
- Oct 30, 2024
- Primary completion
- Sep 30, 2026
- Results posted
- No
- Registry record
- NCT06451614 · updated Oct 13, 2026